{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:19:57Z","timestamp":1789568397184,"version":"build-2803163510"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The histological hallmark of male androgenetic alopecia (MAGA) is the transformation of terminal follicles into miniaturized secondary vellus follicles. As the volume of the dermal papilla determines the size of the hair bulb and hair fibre diameter, any treatment-induced increase in fibre diameter could be used as a proxy for reversal of hair follicle miniaturization. Although clinical trials with minoxidil topical solution in MAGA do not demonstrate increased fibre diameter, vellus-to-terminal reconversion is shown in a humanized mouse model treated with minoxidil.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To investigate whether low-dose sublingual minoxidil (SLM) increases hair fibre diameter in MAGA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Serial tattoo-localized phototrichograms were analysed using hair-to-hair (H2H) matching software in 33 patients with MAGA who participated in a 24-week randomized, double-blinded, placebo-controlled, clinical trial with SLM 0.45\u2005mg once daily. Additional data were obtained from 12 participants who had used a placebo and then rolled into a 24-week, open-label, extension study with either once-daily 1.35\u2005mg or 4.05\u2005mg SLM. TrichoLAB (Warsaw, Masovian, Poland) H2H analysis uniquely identified individual hairs and measured hair fibre diameter at baseline and 24 weeks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After 24 weeks, fibre diameter decreased by 2 \u00b5m (SD 1) in men receiving placebo. The decrease was most marked in intermediate diameter fibres with a baseline diameter of 40\u201360\u2005\u00b5m. Among men receiving SLM 0.45\u2005mg, 1.35\u2005mg and 4.05\u2005mg, the mean increase in fibre diameter was \u22122\u2005\u00b5m (SD 1\u2005\u00b5m), 3\u2005\u00b5m (SD 1\u2005\u00b5m) and 6\u2005\u00b5m (SD 1\u2005\u00b5m), respectively. Intermediate-thickness fibres increased the most. H2H matching demonstrated increased diameter in individual fibres.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The effect of SLM on mean fibre diameter was dose dependent. SLM 1.35\u2005mg and 4.05\u2005mg, but not 0.45\u2005mg, significantly increased mean fibre diameter in MAGA (P &amp;lt; 0.05). The diameter increased most in the intermediate and thickest hairs. This increase in fibre diameter infers reversal of follicle miniaturization in MAGA and is consistent with the observation of vellus-to-terminal reconversion shown in a humanized mouse model treated with minoxidil.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ced\/llaf012","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T23:20:40Z","timestamp":1736205640000},"page":"1362-1365","source":"Crossref","is-referenced-by-count":8,"title":["Sublingual minoxidil increases fibre diameter in male androgenetic alopecia: a proxy for reversal of hair follicle miniaturization"],"prefix":"10.1093","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6751-1428","authenticated-orcid":false,"given":"Rodney","family":"Sinclair","sequence":"first","affiliation":[{"name":"Sinclair Dermatology , Melbourne, VIC ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7907-2837","authenticated-orcid":false,"given":"Justyna","family":"Sicinska","sequence":"additional","affiliation":[{"name":"TrichoLAB AB , Warsaw ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4522-2611","authenticated-orcid":false,"given":"Laita","family":"Bokhari","sequence":"additional","affiliation":[{"name":"Sinclair Dermatology , Melbourne, VIC ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1081-0547","authenticated-orcid":false,"given":"Michal","family":"Kasprzak","sequence":"additional","affiliation":[{"name":"TrichoLAB AB , Warsaw ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"key":"2026030510414930100_llaf012-B1","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/bmj.317.7162.865","article-title":"Male pattern androgenetic alopecia","volume":"317","author":"Sinclair","year":"1998","journal-title":"BMJ"},{"key":"2026030510414930100_llaf012-B2","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1067\/mjd.2001.117428","article-title":"Possible mechanisms of miniaturization during androgenetic alopecia or pattern hair loss","volume":"45","author":"Whiting","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"2026030510414930100_llaf012-B3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1440-0960.2010.00654.x","article-title":"Chronic telogen effluvium is due to a reduction in the variance of anagen duration","volume":"51","author":"Gilmore","year":"2010","journal-title":"Aus J Dermatol"},{"key":"2026030510414930100_llaf012-B4","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1365-4632.2004.02034.x","article-title":"Chronic telogen effluvium or androgenetic alopecia?","volume":"43","author":"Sinclair","year":"2004","journal-title":"Int J Dermatol"},{"key":"2026030510414930100_llaf012-B5","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/bjd.12921","article-title":"Destruction of the arrector pili muscle and fat infiltration in androgenic alopecia","volume":"170","author":"Torkamani","year":"2014","journal-title":"Br J Dermatol"},{"key":"2026030510414930100_llaf012-B6","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1097\/00005344-198000022-00002","article-title":"Pharmacology and pharmacokinetics of minoxidil","volume":"2","author":"Lowenthal","year":"1980","journal-title":"J Cardiovasc Pharmacol"},{"key":"2026030510414930100_llaf012-B7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0009-2797(97)00120-8","article-title":"Sulfation of minoxidil by multiple human cytosolic sulfotransferases","volume":"109","author":"Anderson","year":"1998","journal-title":"Chem Biol Interact"},{"key":"2026030510414930100_llaf012-B8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/j.1552-4604.1989.tb03307.x","article-title":"The pharmacokinetics of 2.5- to 10-mg oral doses of minoxidil in healthy volunteers","volume":"29","author":"Fleishaker","year":"1989","journal-title":"J Clin Pharmacol"},{"key":"2026030510414930100_llaf012-B9","doi-asserted-by":"crossref","first-page":"e13195","DOI":"10.1111\/dth.13195","article-title":"Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil treatment in Brazilian female pattern hair loss patients","volume":"33","author":"Ramos","year":"2020","journal-title":"Dermatol Ther"},{"key":"2026030510414930100_llaf012-B10","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1111\/jdv.16765","article-title":"Minoxidil Sulfotransferase Enzyme (SULT1A1) genetic variants predicts response to oral minoxidil treatment for female pattern hair loss","volume":"35","author":"Ramos","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026030510414930100_llaf012-B11","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jaad.2019.04.054","article-title":"Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia","volume":"81","author":"Jimenez-Cauhe","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"2026030510414930100_llaf012-B12","doi-asserted-by":"crossref","first-page":"e795","DOI":"10.1111\/jdv.16616","article-title":"Treatment of male and female pattern hair loss with sublingual minoxidil: a retrospective case-series of 64 patients","volume":"34","author":"Sinclair","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026030510414930100_llaf012-B13","first-page":"e62","article-title":"Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, \u00addouble-blind, placebo-controlled, phase 1B clinical trial","volume":"36","author":"Bokhari","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026030510414930100_llaf012-B14","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/ajd.12964","article-title":"The Trichoscopy Derived Sinclair Scale: enhancing visual assessment through quantitative trichoscopy","volume":"60","author":"Kasprzak","year":"2019","journal-title":"Aus J Dermatol"},{"key":"2026030510414930100_llaf012-B15","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/exd.14393","article-title":"Following historical \u201ctracks\u201d of hair follicle miniaturization in patterned hair loss: are elastin bodies the forgotten aetiology?","volume":"31","author":"Rushton","year":"2022","journal-title":"Exp Dermatol"},{"key":"2026030510414930100_llaf012-B16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.0909-752X.2006.00202.x","article-title":"Female patients complaining about hair loss: documentation of defective scalp hair dynamics with contrast-enhanced phototrichogram","volume":"12","author":"Van Neste","year":"2006","journal-title":"Skin Res Technol"},{"key":"2026030510414930100_llaf012-B17","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/srt.12827","article-title":"Placebo-controlled dose-effect studies with topical minoxidil 2% or 5% in male-patterned hair loss treated with oral finasteride employing an analytical and exhaustive study protocol","volume":"26","author":"Van Neste","year":"2020","journal-title":"Skin Res Technol"},{"key":"2026030510414930100_llaf012-B18","doi-asserted-by":"crossref","first-page":"12320","DOI":"10.2340\/actadv.v103.12320","article-title":"Vellus-to-terminal hair follicle reconversion occurs in male pattern balding and is promoted by minoxidil and platelet-rich plasma: in vivo evidence from a new humanized mouse model of androgenetic alopecia","volume":"103","author":"Gilhar","year":"2023","journal-title":"Acta Derm Venereol"},{"key":"2026030510414930100_llaf012-B19","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1159\/000524345","article-title":"Efficiency of hair detection in hair-to-hair matched trichoscopy","volume":"8","author":"Bokhari","year":"2022","journal-title":"Skin Appendage Disord"},{"key":"2026030510414930100_llaf012-B20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/jid.1958.121","article-title":"Geometric relationships between the matrix of the hair bulb and its dermal papilla in normal and alopecic scalp","volume":"31","author":"van Scott","year":"1958","journal-title":"J Invest Dermatol"},{"key":"2026030510414930100_llaf012-B21","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/sj.jidsp.5640230","article-title":"Measuring reversal of hair miniaturization in androgenetic alopecia by follicular counts in horizontal sections of serial scalp biopsies: results of finasteride 1\u2005mg treatment of men and postmenopausal women","volume":"4","author":"Whiting","year":"1999","journal-title":"J Investig Dermatol Sym Proc"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llaf012\/61372705\/llaf012.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/50\/7\/1362\/61372705\/llaf012.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/50\/7\/1362\/61372705\/llaf012.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T15:41:57Z","timestamp":1772725317000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/50\/7\/1362\/7945317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,8]]},"references-count":21,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,1,8]]},"published-print":{"date-parts":[[2025,6,25]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llaf012","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,1,8]]}}}